"In the second quarter, we are anticipating revenue in the range of $680 million to $700 million" and "we expect adjusted EBITDA to be between $35 million to $55 million." (CFO Okupe) "For the full ...
Hims & Hers Health has spent the past month surprising Wall Street with a 32% rally, all while more than a third of its available shares are held by investors betting the stock will fall. Today, the ...
A month has gone by since the last earnings report for Hims & Hers Health, Inc. (HIMS). Shares have added about 15.8% in that time frame, outperforming the S&P 500. Will the recent positive trend ...
Asianet Newsable on MSN
HIMS stock hits 2026 high after unlocking $400M working capital through JPMorgan — retail gets less bearish
The uncommitted facility provides Hims with a working-capital tool as it scales its healthcare and pharmacy operations.
SAN FRANCISCO--(BUSINESS WIRE)--Hims & Hers Health, Inc. (“Hims & Hers”, NYSE: HIMS), the leading health and wellness platform, today announced that it will report first quarter 2026 financial results ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results